198 related articles for article (PubMed ID: 6103880)
1. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
Gachályi B; Tornyossy M; Vas A; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
[TBL] [Abstract][Full Text] [Related]
2. Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
Malaka-Zafiriu K; Koliouskas D; Kontopoulos E; Danielides B; Cassimos C
Helv Paediatr Acta; 1981; 36(2):149-58. PubMed ID: 6114077
[TBL] [Abstract][Full Text] [Related]
3. [Effect of alpha methyldopa on the mixed oxygenase system of the liver in man].
Gachályi B; Tornyossy M; Vas A; Káldor A
Orv Hetil; 1979 Apr; 120(15):897-8. PubMed ID: 372883
[No Abstract] [Full Text] [Related]
4. [Biological tests as indirect indicators of the activity of drug metabolizing enzymes. Use of glucaric acid and gamma-glutamyltransferase].
Siest G; Batt AM; Galteau MM
Ann Biol Clin (Paris); 1977; 35(6):425-32. PubMed ID: 28055
[TBL] [Abstract][Full Text] [Related]
5. m-Trifluoromethyl-alpha-ethylbenzhydrol: a new enzyme inducer.
Gachályi B; Káldor A; Szeberényi S
Eur J Clin Pharmacol; 1978 Jun; 13(4):299-302. PubMed ID: 668788
[TBL] [Abstract][Full Text] [Related]
6. Drug metabolism in alcoholic liver disease.
Horváth T; Pár A; Past T; Tapsonyi Z; Ruzsa C; Kádas I; Jávor T
Acta Med Acad Sci Hung; 1982; 39(3-4):169-77. PubMed ID: 7185242
[No Abstract] [Full Text] [Related]
7. [D-glucaric acid excretion in kidney transplant patients as an indicator of microsomal enzyme capacity].
Jung K; Scholz D; Schreiber G
Z Urol Nephrol; 1982 Jun; 75(6):387-91. PubMed ID: 6126971
[TBL] [Abstract][Full Text] [Related]
8. Variable inhibition of human hepatic drug metabolizing enzymes by disulfiram.
Freundt KJ
Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):323-30. PubMed ID: 669879
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
Pár A; Horváth T; Beró T; Kádas I; Pakodi F; Jávor T
Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369
[TBL] [Abstract][Full Text] [Related]
10. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
Perry W; Jenkins MV
Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
[TBL] [Abstract][Full Text] [Related]
11. Production of endogenous D-glucaric acid and oxidative N-demethylation of amidopyrine in man: lack of correlation.
Freundt KJ
Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):104-6. PubMed ID: 429081
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
Traeger A; Horváth T; Rechenbach C; Jávor T
Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of D-glucaric acid in human urine after repeated administration of pyrithioxine.
Freundt KJ; Liedy G; Voigt HO
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):639-42. PubMed ID: 6526537
[TBL] [Abstract][Full Text] [Related]
14. Effects of phenobarbital on unconjugated bilirubin clearance, gamma-glutamyltranspeptidase and urinary d-glucaric acid in patients with Gilbert's syndrome.
Kawasaki H; Murawaki Y; Kimura N; Hirayama C
Hepatogastroenterology; 1982 Dec; 29(6):252-5. PubMed ID: 6130037
[TBL] [Abstract][Full Text] [Related]
15. Effect of a non-steroid anti-inflammatory agent on the drug metabolizing activity of the human liver.
Gachályi B; Vas A; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):353-4. PubMed ID: 6469424
[TBL] [Abstract][Full Text] [Related]
16. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.
Buchanan N; Eyberg C; Davis MD
Am J Clin Nutr; 1979 Dec; 32(12):2439-42. PubMed ID: 506967
[TBL] [Abstract][Full Text] [Related]
17. The effect of oral contraceptives on serum lipids gamma-glutamyl transpeptidase, and excretion of d-glucaric acid.
Hajós P; Berlin I; Intödy Z; Tornyossy M; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):117-23. PubMed ID: 6112206
[TBL] [Abstract][Full Text] [Related]
18. Hepatic microsomal enzyme induction and its evaluation in a clinical laboratory.
Herzberg M; Fishel B; Wiener MH
Isr J Med Sci; 1977 May; 13(5):471-6. PubMed ID: 17578
[TBL] [Abstract][Full Text] [Related]
19. Combined effect of alpha-methyldopa and a new enzyme inducer, Zixoryn, on the hepatic mixed-function monooxygenase system in humans.
Gachályi B; Vas A; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):183-5. PubMed ID: 6862721
[TBL] [Abstract][Full Text] [Related]
20. Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.
Smith SE; Rawlins MD
Eur J Clin Pharmacol; 1974; 7(1):71-5. PubMed ID: 4153008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
